Safety of fecal microbiota, live-jslm (REBYOTA) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials
By stimulating GLP-1 receptors, semaglutide leads to feelings of fullness, reduced cravings, and slower digestion, ultimately promoting weight loss
Many payers have specific policies for compounded GLP-1 medications that may limit coverage
To combat this, we advise our patients to eat small, frequent meals rather than sticking to the traditional three large meals a day
Iron pills can sometimes make stools appear dark, but thats not because they cause any bleeding
And protein is the most important nutrient for combatting such loss